Clear Cell Carcinoma of the Ovary: Prognosis Using Cytoreductive Surgery
作者： Masashi Takano , Naoki Sasaki , Toru Sugiyama
DOI: 10.1007/978-90-481-2918-8_7
关键词:
摘要: Clear cell carcinoma of the ovary was initially termed as “mesonerhroma ovarii” by Schiller (1939), tumor resembled renal and believed to originate from mesonephric structure. Approximately, three decades ago, it strictly defined World Health Organization classification ovarian tumors (Serov et al. 1973) lesions characterized clear cells growing in solid/tubular or glandular patterns well hobnail cells. Recently, many publications have identified distinctive clinical behavior carcinoma; resistance platinum-based chemotherapy (Omura 1991) poor prognosis comparison with other histologic subtypes (Sugiyama 2000; Pectasides 2006). The distinguished characteristics are described this chapter: molecular after comprehensive cytoreductive surgery.
springer.com
sci-hub.st 参考文章(36)
Sobin Lh, International Histologic Classification of Tumors Bulletin of The World Health Organization. ,vol. 60, pp. 171- 178 ,(1982)
Fumiko Saito-Ohara, Daisuke Aoki, Issei Imoto, Johji Inazawa, Nobuyuki Susumu, Tetsuji Yokoyama, Jun Inoue, Jun Inoue, Akira Hirasawa, Shiro Nozawa, Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets. Clinical Cancer Research. ,vol. 9, pp. 1995- 2004 ,(2003)
Akira Tsuchiya, Michiie Sakamoto, Jun Yasuda, Makoto Chuma, Tsutomu Ohta, Misao Ohki, Toshiharu Yasugi, Yuji Taketani, Setsuo Hirohashi, Expression Profiling in Ovarian Clear Cell Carcinoma: Identification of Hepatocyte Nuclear Factor-1β as a Molecular Marker and a Possible Molecular Target for Therapy of Ovarian Clear Cell Carcinoma American Journal of Pathology. ,vol. 163, pp. 2503- 2512 ,(2003) , 10.1016/S0002-9440(10)63605-X
G A Omura, M F Brady, H D Homesley, E Yordan, F J Major, H J Buchsbaum, R C Park, Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. Journal of Clinical Oncology. ,vol. 9, pp. 1138- 1150 ,(1991) , 10.1200/JCO.1991.9.7.1138
Hajime Tsunoda, Masato Nishida, Yasuhiko Takimoto, Nakako Sato, Yukio Morishita, Takeshi Kubo, Masayuki Noguchi, Loss of Heterozygosity on 10q23.3 and Mutation of the Tumor Suppressor Gene PTEN in Benign Endometrial Cyst of the Ovary: Possible Sequence Progression from Benign Endometrial Cyst to Endometrioid Carcinoma and Clear Cell Carcinoma of the Ovary Cancer Research. ,vol. 60, pp. 7052- 7056 ,(2000)
Takashi Onda, Hiroyuki Yoshikawa, Toshiharu Yasugi, Misako Mishima, Shunsuke Nakagawa, Manabu Yamada, Koji Matsumoto, Yuji Taketani, Patients with ovarian carcinoma upstaged to Stage III after systematic lymphadenctomy have similar survival to Stage I/II patients and superior survival to other Stage III patients Cancer. ,vol. 83, pp. 1555- 1560 ,(1998) , 10.1002/(SICI)1097-0142(19981015)83:8<1555::AID-CNCR10>3.0.CO;2-R
Kian Behbakht, Thomas C. Randall, Ivor Benjamin, Mark A. Morgan, Stephanie King, Stephen C. Rubin, Clinical Characteristics of Clear Cell Carcinoma of the Ovary Gynecologic Oncology. ,vol. 70, pp. 255- 258 ,(1998) , 10.1006/GYNO.1998.5071
Esther Shih-Chu Ho, Chiung-Ru Lai, Yeun-Ting Hsieh, Jung-Ta Chen, Ai-Jane Lin, Man-Jung Hung, Fu-Shing Liu, p53 Mutation Is Infrequent in Clear Cell Carcinoma of the Ovary Gynecologic Oncology. ,vol. 80, pp. 189- 193 ,(2001) , 10.1006/GYNO.2000.6025
Toru Sugiyama, Toshiharu Kamura, Junzo Kigawa, Naoki Terakawa, Yoshihiro Kikuchi, Tunekazu Kita, Mitsuaki Suzuki, Ikuo Sato, Kouji Taguchi, Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer. ,vol. 88, pp. 2584- 2589 ,(2000) , 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5
Noriaki Sakuragi, Hiroaki Negishi, Mahito Takeda, Toshio Fujimoto, Yukiharu Todo, Yasuhiko Ebina, Hidemichi Watari, Ritsu Yamamoto, Hisanori Minakami, Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer. Gynecologic Oncology. ,vol. 94, pp. 161- 166 ,(2004) , 10.1016/J.YGYNO.2004.04.023